IL6 and systemic sclerosis: The analyses of the mechanism of action of MT-7117 in the BLM-induced SSc model revealed that its primary action is anti-inflammatory via suppression of activation of inflammatory cells, such as monocytes/macrophages, and inflammation-related signals, such as IL-6 signaling.